Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	34.08	59.42	44.32
Graham Fair Price	-89.86	3.64	35.92
PEG	82632.24	27.82	0.03
Price/Book	38.11	2.27	1.64
Price/Cash Flow	-49.90	93.43	186.49
Prices/Earnings	12904.34	-2811.02	21.62
Price/Sales	45.13	10.18	7.02
Price/FCF	-49.90	93.43	186.49
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	5.96	0.36	0.34
Operating Margin	0.71	0.15	0.14
ROA	-98.94	< 0.005	< 0.005
ROE	0.02	< 0.005	-98.94
ROIC	0.02	< 0.005	-57.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	0.03	7.57
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.34	-0.06	-83.84
EPS QOQ	6.43	-1.01	-84.28
FCF QOQ	-0.74	1.72	131.51
Revenue QOQ	0.11	-0.06	-42.71
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	11.28	12.37	9.65
Days Sales Outstanding (DSO)	53.94	49.01	-9.14
Inventory Turnover	7.98	7.28	-8.80
Debt/Capitalization	0.32	0.32	-1.01
Quick Ratio	0.69	0.57	-17.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	54.98	54.12	-1.57
Cash	3.93	3.62	-7.85
Capex	-0.71	-0.69	3.18
Free Cash Flow	0.48	1.31	171.37
Revenue	12.85	12.04	-6.33
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.84	0.75	-10.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.72	8.91	2.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating